Treatment with 17-allylamino-17-demethoxygeldanamycin ameliorated symptoms of Bartter syndrome type IV caused by mutated Bsnd in mice.
In: Biochemical & Biophysical Research Communications, Jg. 441 (2013-11-22), Heft 3, S. 544-549
academicJournal
Zugriff:
Highlights: [•] R8L barttin knock-in mice exhibited sensorineural hearing impairment. [•] Plasma membrane expression of R8L barttin was impaired in marginal cells of the inner ear. [•] 17-AAG enhanced plasma membrane localization of R8L barttin in the inner ear and kidney. [•] 17-AAG improved hearing of R8L barttin knock-in mice. [Copyright &y& Elsevier]
Titel: |
Treatment with 17-allylamino-17-demethoxygeldanamycin ameliorated symptoms of Bartter syndrome type IV caused by mutated Bsnd in mice.
|
---|---|
Autor/in / Beteiligte Person: | Nomura, Naohiro ; Kamiya, Kazusaku ; Ikeda, Katsuhisa ; Yui, Naofumi ; Chiga, Motoko ; Sohara, Eisei ; Rai, Tatemitu ; Sakaki, Sei ; Uchida, Shinich |
Zeitschrift: | Biochemical & Biophysical Research Communications, Jg. 441 (2013-11-22), Heft 3, S. 544-549 |
Veröffentlichung: | 2013 |
Medientyp: | academicJournal |
ISSN: | 0006-291X (print) |
DOI: | 10.1016/j.bbrc.2013.10.129 |
Schlagwort: |
|
Sonstiges: |
|